Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Speech Plus appears to refer to a speech-language pathology or speech therapy related business rather than a biotech, pharmaceutical, or therapeutics developer. Based on the name alone, it is most plausibly associated with healthcare service delivery in communication disorders, such as speech and language evaluation and therapy. However, the exact legal entity, operating status, ownership, and service scope cannot be confidently determined from the provided name alone. No verified evidence was established here for a drug pipeline, therapeutic development platform, or life sciences R&D program. This record should therefore be treated as a low-confidence placeholder pending identification of the precise company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Speech Plus.